Inflammatory mechanisms and anti-inflammatory therapy in Alzheimer's disease

Neurobiology of Aging

Volumn 17, Issue 5, 1996, Pages 669-671

  O'Banion, M K ^a   Finch, C E ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; EDITORIAL; HUMAN; NERVOUS SYSTEM INFLAMMATION; NEUROPATHY; PRIORITY JOURNAL;

EID: 0029973611     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/0197-4580(96)00102-9     Document Type: Editorial

References (39)

1. A. Alzheimer Uber eine eigenartige Erkrankung der Hindrinde E. Schultze O. Snell Allgemeine Zietschrrift fur Psychiatrie und Psychisch-Gerichtliche Medizin vol. LXIV 1907 Georg Reimer Berlin 146 148
2. A. Alzheimer A characteristic disease of the cerebral cortex Translated as K. Bick L. Amaducci G. Pepeu The early story of Alzheimer's disease 1987 Livinia Press Padov 1 3 Distributed through Raven Press: New York City
3. D.M. Bowen C.B. Smith P. White A.N. Davison Neurotransmitter-related enzymes and indices of hypoxia in senile and dementia and other abiotrophies Brain 99 1976 459 496
4. J.C.S. Breitner B.A. Gau K.A. Welsh B.L. Plassman W.M. McDonald M.J. Helms J.C. Anthony Inverse association of anti-inflammatory treatments and Alzheimer's disease: Initial results of a co-twin control study Neurology 44 1994 227 232
5. J.C.S. Breitner K.A. Welsh M.J. Helms P.C. Gaskell B.A. Gau A.D. Roses M.A. Pericak-Vance A.M. Saunders Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H-2 blocking drugs Neurobiol. Aging 16 1995 523 530
6. E. Calkins J.D. Reinhard A.O. Vladutiu Rheumatoid arthritis and the autoimmune rheumatic diseases in the older patient W.R. Hazzard E.L. Bierman J.P. Blass W.H. Ettinger J.B. Halter R. Andres Principles of geriatric medicine and gerontology 1993 McGraw-Hill, Inc New York 965 980
7. P. Davies A.J.F. Maloney Selective loss of central cholinergic neurons in Alzheimer's disease Lancet 2 1976 1403
8. D.A. Drachman J. Leavitt Human memory and the cholinergic system Arch. Neurol. 30 1974 113 121
9. P. Eikelenboom F.C. Stam Immunoglobulins and complement factors in senile plaques. An histochemical study Acta Neuropathol. 57 1982 239 242
10. C.E. Finch J. Marchalonis Evolutionary perspectives on amyloid and inflammatory features of Alzheimer disease Neurobiol. Aging 17 1996 000 000
11. R.S. Fife Osteoarthritis W.R. Hazzard E.L. Bierman J.P. Blass W.H. Ettinger J.B. Halter R. Andres Principles of Geriatric medicine and Gerontology 1993 McGraw-Hill, Inc New York 981 986
12. G.S. Firestein N.J. Zvaifler Rheumatoid arthritis: A disease of disordered immunity J.I. Gallin I.M. Goldstein R. Snyderman Inflammation: Basic principles and clinical correlates 1992 Raven Press New York 959 975
13. G.G. Glenner Current knowledge of amyloid deposits as applied to senile plaques and congophilic angiopathy R. Katzman R.D. Terry K.L. Bick Alzheimer's disease: Senile dementia and related disorders 1978 Raven Press New York 493 501
14. G.G. Glenner C.W. Wong Alzheimer's disease: Initial report on the purification and characterization of a novel cerebrovascular amyloid protein Biochem. Biophys. Res. Commun. 120 1984 885 890
15. W.S.T. Griffin L.C. Stanley C. Ling L. White V. MacLeod L.J. Perrot C.L. White III C. Araoz Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease 8th ed Proc. Natl. Acad. Sci. USA 86 1989 7611 7615
16. P.N. Hawkins S. Richardson D.M. Vigushin J. David C.R. Kelsey R.E.S. Grey M.A. Hall P. Woo J.P. Lavender Serum amyloid-P component scintigraphy and turnover studies for diagnosis and quantitative monitoring of AA-amyloidoisis in juvenile rheumatoid-arthritis Arthritis Rheum. 36 1993 842 851
17. T. Ishii S. Haga Identification of components of immunoglobulins in senile plaques by means of fluorescent antibody technique Acta Neuropathol. 32 1975 157 162
18. T. Ishii S. Haga Immuno-electron microscopic localization of immunoglobulins in amyloid fibrils of senile plaques Acta Neuropathol. 36 1976 243 249
19. M.L. Jenkinson M.R. Bliss A.T. Brain D.L. Scott Rheumatoid arthritis and senile dementia of the Alzheimer's type Br. J. Rheumatol. 26 1989 86 88
20. H. Jiang D. Burdick C.G. Glabe C.W. Cotman A.J. Tenner β-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain J. Immunol. 152 1994 5050 5059
21. S.A. Johnson M. Lampert-Etchells I. Rozovsky G. Pasinetti C.E. Finch Complement mRNA in the mammalian brain: Responses to Alzheimer's disease and experimental lesions Neurobiol. Aging 13 1992 641 648
22. R. Kisilevsky Inflammation-associated amyloidogenesis: Lessons for Alzheimer's amyloidogenesis Mol. Neurobiol. 8 1994 65 66
23. C.L. Masters G. Simms N.A. Weinman G. Multhaup B.L. McDonald K. Beyreuther Amyloid plaque core protein in Alzheimer's disease and Down syndrome 8th ed Proc. Natl. Acad. Sci. USA 82 1985 4245 4249
24. P.C. May M. Lampert-Etchells S.A. Johnson J. Poirier J.N. Masters C.E. Finch Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer's disease and in response to experimental lesions in rat Neuron 5 1990 831 839
25. P.L. McGeer H. Akiyama S. Itagaki E.G. McGeer Immune system response in Alzheimer's disease Can. J. Neurol. Sci. 16 1989 516 527
26. P.L. McGeer H. Akiyama S. Itagaki E.G. McGeer Activation of the classical complement pathway in brain tissue of Alzheimer patients Neurosci. Lett. 107 1989 341 346
27. P.L. McGeer E.G. McGeer J. Rogers J. Sibley Anti-inflammatory drugs and Alzheimer disease Lancet 335 1991 1037
28. P.L. McGeer E.G. McGeer J. Rogers Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease Neurology 42 1992 447 448
29. G.M. Pasinetti S.A. Johnson I. Rozovsky M. Lampert-Etchells D.G. Morgan M.N. Gordon T.E. Morgan D.A. Willoughby C.E. Finch Complement mRNA responses to lesioning in rat brain Exp. Neurol. 118 1992 117 125
30. M.B. Pepys Amyloidosis M. Samter D.W. Talmage M.M. Frank K.F. Austen H.H. Claman Immunological diseases 1988 Little, Brown and Company Boston 631 674
31. J.B. Rich D.X. Rasmusson M.F. Folstein K.A. Carson C. Kawas J. Brandt Nonsteroidal anti-inflammatory drugs in Alzheimer's disease Neurology 45 1995 51 55
32. J. Rogers N.R. Cooper S. Webster J. Schultz P.L. McGeer S.D. Styren W.H. Civin L. Brachova B. Bradt P. Ward I. Lieberburg Complement activation by β-amyloid in Alzheimer disease 8th ed Proc. Natl. Acad. Sci. USA 89 1992 1016 1020
33. J. Rogers L.C. Kirby S.R. Hempelman D.L. Berry M.D. McGeer A.W. Kaszniak J. Zalinski M. Cofield L. Mansukhani P. Willson F. Kogan Clinical trial of indomethacin in Alzheimer's disease Neurology 43 1993 1609 1611
34. J. Rogers J. Luber-Narod S.D. Styren W.H. Civin Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease Neurobiol. Aging 9 1988 339 349
35. G.H. Sack M.C. Zing Serum amyloid A gene transcription in synovial cells during retroviral arthritis Am. J. Pathol. 141 1992 525 529
36. P. Schwartz Amyloidosis: Cause and manifestations of senile deterioration 1970 C. C. Thomas Springfield
37. J.D. Sipe Acute-phase proteins in osteoarthritis Semin. Arthritis Rheum. 25 1995 75 86
38. R.D. Terry N.K. Gonatas M. Weiss Ultrastructural studies in Alzheimer's presenile dementia Am. J. Pathol. 44 1964 269 297
39. H.M. Wisniewski R.D. Terry Reexamination of the pathogenesis of the senile plaques Progress in Neuropathology 1973 Grune and Stratton New York 1 26